Glycopyrrolate Improves Disability From Sialorrhea in Parkinson's Disease: A 12-Week Controlled Trial.

Tiago A Mestre Maria Eliza FreitasAhmed BasndwahMarta Ruiz LopezLais Machado de OliveiraDuha Mohammed Al-ShorafatTinghua ZhangJane P LuiDavid GrimesSusan H Fox

Published in: Movement disorders : official journal of the Movement Disorder Society (2020)

The results support the efficacy of glycopyrrolate to treat sialorrhea-related disability up to 12 weeks and contribute to addressing unmet nonmotor care needs in PD. © 2020 International Parkinson and Movement Disorder Society.

Keyphrases

multiple sclerosis
healthcare
parkinson disease
palliative care
quality improvement
open label
double blind
pain management
gestational age
affordable care act